These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8312978)

  • 1. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
    Tollefson GD; Fawcett J; Winokur G; Beasley CM; Potvin JH; Faries DE; Rampey AH; Sayler ME
    Ann Clin Psychiatry; 1993 Dec; 5(4):209-24. PubMed ID: 8312978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between fluoxetine and suicidality in bulimia nervosa.
    Wheadon DE; Rampey AH; Thompson VL; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression.
    Tollefson GD; Rampey AH; Beasley CM; Enas GG; Potvin JH
    J Clin Psychopharmacol; 1994 Jun; 14(3):163-9. PubMed ID: 8027412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine: no association with suicidality in obsessive-compulsive disorder.
    Beasley CM; Potvin JH; Masica DN; Wheadon DE; Dornseif BE; Genduso LA
    J Affect Disord; 1992 Jan; 24(1):1-10. PubMed ID: 1545040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicidality and fluoxetine: is there a relationship?
    Fava M; Rosenbaum JF
    J Clin Psychiatry; 1991 Mar; 52(3):108-11. PubMed ID: 2005073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.
    Tauscher-Wisniewski S; Disch D; Plewes J; Ball S; Beasley CM
    Psychol Med; 2007 Nov; 37(11):1585-93. PubMed ID: 17640442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies in the Pharmacotherapy of Adolescent Depression.
    Masi G
    Curr Pharm Des; 2022; 28(24):1975-1984. PubMed ID: 35619257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating the substance-abusing suicidal patient.
    Cornelius JR; Salloum IM; Lynch K; Clark DB; Mann JJ
    Ann N Y Acad Sci; 2001 Apr; 932():78-90; discussion 91-3. PubMed ID: 11411192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine not associated with increased aggression in controlled clinical trials.
    Heiligenstein JH; Beasley CM; Potvin JH
    Int Clin Psychopharmacol; 1993; 8(4):277-80. PubMed ID: 8277148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts.
    Mulder RT; Joyce PR; Frampton CM; Luty SE
    Acta Psychiatr Scand; 2008 Aug; 118(2):116-22. PubMed ID: 18384467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.
    Stone M; Laughren T; Jones ML; Levenson M; Holland PC; Hughes A; Hammad TA; Temple R; Rochester G
    BMJ; 2009 Aug; 339():b2880. PubMed ID: 19671933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder.
    Garlow SJ; Kinkead B; Thase ME; Judd LL; Rush AJ; Yonkers KA; Kupfer DJ; Frank E; Schettler PJ; Rapaport MH
    J Psychiatr Res; 2013 Sep; 47(9):1199-203. PubMed ID: 23786912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant drugs and the emergence of suicidal tendencies.
    Teicher MH; Glod CA; Cole JO
    Drug Saf; 1993 Mar; 8(3):186-212. PubMed ID: 8452661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.